Phenotypes defined by the "Vienna classification" in 100 Hungarian patients with Crohn's disease;Fenotipos definidos según la "Clasificación de Viena" en 100 pacientes húngaros con enfermedad de Crohn

Revista Espanola de Enfermedades Digestivas

Volumn 95, Issue 8, 2003, Pages 533-538

  Nemetz, A ^a,b   Molnar T ^c   Zagoni T ^a   Kovacs A ^d   Tulassay, Z ^a   Nagy, F ^c   Salvador Pena A ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Erzsebet Hospital   (Hungary)

Author keywords

Cronh's disease; Disease course; Female; Male; Phenotypes; Prognosis; Vienna classification

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC DIFFERENCE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; STANDARDIZATION; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

ADULT; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNGARY; MALE; PHENOTYPE;

EID: 0042232433     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bayless TM, Tokayer AZ, Polito II JM, Quaskey SA, Mellits ED, Harris ML. Crohn's disease: concordance for site and clinical type in affected family members - potential hereditary influences. Gastroenterology 1996; 111: 573-9.
2. Bouma G, Poen AC, García-González MA, Schreuder GMT, Felt-Bersma RJF, Meuwissen SGM, et al. HLA-DRB1*03, but not a TNFA -308 promoter gene polymorphism confers protection against fistulising Crohn's disease. Immunogenetics 1998; 47: 451-5.
3. Perri F, Annese V, Napolitano G, Caruso N, Clemente R, Villani MR, et al. Subgroups of patients with Crohn's disease have different clinical outcomes. Inflamm Bowel Dis 1996; 2: 1-5.
4. Nemetz A, Nosti-Escanilla M, Molnár T, Köpe A, Kovács Á, Fehér J, et al. IL-1 beta gene polymorphisms influence the course and severity of Inflammatory Bowel Disease. Immunogenetics 1999; 49: 527-31.
5. Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000; 118: 274-8.
6. Linares de la Cal JA, Canton C, Hermida C, Pérez-Miranda M, Mate-Jimenez J. Estimated incidence of inflammatory bowel disease in Argentina and Panama (1987-1993). Rev Esp Enferm Dig 1999; 91: 277-86.
7. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149: 916-24.
8. Rozen P, Zonis J, Yekutiel P, Gilat T. Crohn's disease in the Jewish population of Tel-Aviv-Yafo. Epidemiologic and clinical aspects. Gastroenterology 1979; 76: 25-30.
9. Binder V, Both H, Hansen PK, Hendriksen C, Kreiner S, Torp-Pedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology 1982; 83: 563-8.
10. Odes HS, Fraser D, Krugliak P, Fenyves D, Fraser GM, Sperber AD. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut 1991; 32: 1024-6.
11. Gasche C. The Vienna Classification of Crohn's disease. Inflamm Bowel Dis 2000.
12. Sachar DB, Andrews HA, Farmer RG, Pallone F, Peña AS, Prantera C, et al. Proposed classification of patients subgroups in Crohn's disease. Working team report. Gastroenterol Int 1992; 5: 141-54.
13. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg 2000; 87: 1697-701.
14. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818-25.
15. Lind E, Fausa O, Elgjo K, Gjone E. Crohn's disease. Clinical manifestations. Scand J of Gastroenterol 1985; 20: 665-70.
16. Greenstein AJ, Geller SA, Dreiling DA, Aufses AH, Jr. Crohn's disease of the colon. IV. Clinical features of Crohn's (ileo) colitis. Am J Gastroenterol 1975; 64: 191-9.
17. Polito JM, 2nd, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111: 580-6.
18. Regimbeau JM, Panis Y, Marteau P, Benoist S, Valleur P. Surgical treatment of anoperineal Crohn's disease: can abdominoperineal resection be predicted? J Am Coll Surg 1999; 189: 171-6.
19. Strong SA. Prognostic parameters of Crohn's disease recurrence. Baillieres Clin Gastroenterol 1998; 12: 167-77.
20. Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM. Growth and clinical course of children with Crohn's disease. Gut 1993; 34: 939-43.
21. Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 1998; 4: 182-6.
22. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology 1998; 114: 1143-50.
23. Guglielmino CR, Beres J. Genetic structure in relation to the history of Hungarian ethnic groups. Hum Biol 1996; 68: 335-55.
24. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 Supl. 170: 2-6.
25. Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999; 45: 395-401.
26. Sung JJ, Hsu RK, Chan FK, Liew CT, Lau JW, Li AK. Crohn's disease in the Chinese population. An experience from Hong Kong. Dis Colon Rectum 1994; 37: 1307-9.
27. Stetter M, Schuster E, Knoflach P. Long-term follow-up of Crohn disease. Z Gastroenterol 1992; 30: 454-8.
28. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000; 12: 31-8.
29. Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am 1990; 74: 39-50.
30. Maeda K, Okada M, Yao T, Sakurai T, Iida M, Fuchigami T, et al. Intestinal and extraintestinal complications of Crohn's disease: predictors and cumulative probability of complications. J Gastroenterol 1994; 29: 577-82.
31. Lind E, Fausa O, Gjone E, Mogensen SB. Crohn's disease. Treatment and outcome. Scand J Gastroenterol 1985; 20: 1014-8.
32. Rankin GB, Watts HD, Melnyk CS, Kelley ML, Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77: 914-20.
33. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976; 55: 401-12.
34. Triantafillidis JK, Emmanouilidis A, Nicolakis D, Ifantis T, Cheracakis P, Merikas EG. Crohn's disease in the elderly: clinical features and long-term outcome of 19 Greek patients. Dig Liver Dis 2000; 32: 498-503.
35. Grimm IS, Friedman LS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 1990; 19: 361-89.
36. Gollop JH, Phillips SF, Melton LJd, Zinsmeister AR. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988; 29: 49-56.
37. Price WH. A high incidence of chronic inflammatory bowel disease in patients with Turner's syndrome. J Med Genet 1979; 16: 263-6.
38. Heresbach D, Gulwani-Akolkar B, Lesser M, Akolkar PN, Lin XY, Heresbach-Le Berre N, et al. Anticipation in Crohn's disease may be influenced by gender and ethnicity of the transmitting parent. Am J Gastroenterol 1998; 93: 2368-72.
39. Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine 1996; 75: 124-30.
40. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114: 1045-56.
41. Sunyer T, Lewis J, Collin-Osdoby P, Osdoby P. Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J Clin Invest 1999; 103: 1409-18.
42. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33: 779-82.